3-46863300-G-A
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 3P and 6B. PM1PP2BP4_ModerateBS2
The NM_000258.3(MYL3):c.91C>T(p.Arg31Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R31H) has been classified as Likely benign.
Frequency
Consequence
NM_000258.3 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hypertrophic cardiomyopathy 8Inheritance: AD, SD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- dilated cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| MYL3 | NM_000258.3 | c.91C>T | p.Arg31Cys | missense_variant | Exon 1 of 7 | ENST00000292327.6 | NP_000249.1 | |
| MYL3 | NM_001406937.1 | c.91C>T | p.Arg31Cys | missense_variant | Exon 1 of 6 | NP_001393866.1 | ||
| MYL3 | NM_001406938.1 | c.91C>T | p.Arg31Cys | missense_variant | Exon 3 of 9 | NP_001393867.1 | ||
| MYL3 | NM_001406939.1 | c.91C>T | p.Arg31Cys | missense_variant | Exon 3 of 9 | NP_001393868.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000263  AC: 4AN: 152236Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000160  AC: 4AN: 250322 AF XY:  0.0000148   show subpopulations 
GnomAD4 exome  AF:  0.0000109  AC: 16AN: 1461740Hom.:  0  Cov.: 32 AF XY:  0.0000124  AC XY: 9AN XY: 727186 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000263  AC: 4AN: 152236Hom.:  0  Cov.: 32 AF XY:  0.0000269  AC XY: 2AN XY: 74376 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
The Arg31Cys variant has been identified in 1/8600 European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.wa shington.edu/EVS), though it cannot be ruled out that the individual was presymp tomatic. Computational analyses (biochemical amino acid properties, conservation , AlignGVGD, PolyPhen2, and SIFT) suggest that this variant may not impact the p rotein, though this information is not predictive enough to rule out pathogenici ty. Additional information is needed to fully assess the clinical significance o f the Arg31Cys variant. -
not provided    Uncertain:1 
Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 43131; Landrum et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 27600370) -
Hypertrophic cardiomyopathy    Uncertain:1 
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 31 of the MYL3 protein (p.Arg31Cys). This variant is present in population databases (rs377026344, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with MYL3-related conditions. ClinVar contains an entry for this variant (Variation ID: 43131). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype    Uncertain:1 
The c.91C>T (p.R31C) alteration is located in exon 1 (coding exon 1) of the MYL3 gene. This alteration results from a C to T substitution at nucleotide position 91, causing the arginine (R) at amino acid position 31 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Hypertrophic cardiomyopathy 1    Uncertain:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at